Chemours Co
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 81.6% | 81.9% | 79.1% | 80.2% | 80.9% | 80.4% | 82.7% | 82.8% | 84.3% | 88.5% | 84.4% | 82.0% | 84.7% | |
| 18.4% | 18.1% | 20.9% | 19.8% | 19.1% | 19.6% | 17.3% | 17.2% | 15.7% | 11.5% | 15.6% | 18.0% | 15.3% | |
| 1.9% | 1.1% | 2.1% | 1.7% | 1.9% | 1.9% | 2.0% | 1.7% | 1.7% | 2.0% | 1.9% | 1.7% | 1.8% | |
| 11.1% | 15.8% | 10.2% | 8.9% | 9.0% | 10.3% | 9.0% | 27.1% | 7.3% | 9.8% | 10.6% | 29.5% | 14.7% | |
| 11.0% | 10.5% | 12.6% | 11.5% | 10.9% | 14.2% | 11.5% | 12.8% | 8.8% | 31.0% | 10.9% | 31.4% | 20.6% | |
| 7.4% | 7.6% | 8.3% | 8.4% | 8.1% | 5.4% | 5.7% | 4.5% | 7.0% | -19.5% | 4.6% | -13.4% | -5.2% | |
| 3.7% | 4.5% | 4.6% | 4.2% | 4.6% | 4.8% | 4.8% | 4.1% | 4.5% | 5.2% | 4.9% | 4.3% | 4.7% | |
| 0.9% | -4.9% | 5.1% | 4.4% | -2.0% | 0.6% | 5.7% | -16.2% | 3.4% | -10.9% | -1.6% | -0.1% | -2.0% | |
| 0.1% | -3.8% | 1.2% | 0.6% | -0.2% | 1.2% | 6.0% | 7.4% | -0.6% | -6.2% | 0.5% | 17.2% | 3.2% | |
| 0.8% | -1.3% | 4.0% | 3.9% | -1.8% | -0.6% | -0.3% | -23.6% | 4.0% | -4.6% | -2.1% | -17.2% | -5.2% | |
| 9.7% | 12.0% | 15.0% | 13.4% | 7.8% | 11.0% | 11.3% | -7.1% | 13.2% | -5.7% | 9.1% | -26.0% | -2.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.